Search

58 results in Keywords: drug repurposing

In Silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19

Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, Cristian Robert Munteanu, Eduardo Tejera, Esteban Ortiz-Prado, Doménica Cevallos-Robalino, Ana María Gómez J., Katherine Simbaña-Rivera, Adriana Granizo-Martínez, Gabriela Pérez-M, Jennyfer M. García-Cárdenas, Ana Karina Zambrano, Silvana Moreno, Yunierkis Pérez-Castillo, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Carolina Proaño-Castro, Jhomayra Bautista, Nelson Varela, Luis Abel Quiñones, Cesar Paz-y-Miño

Version 1 posted 03 June 2020

2,229

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach

Rodrigo R. R. Duarte, Dennis C. Copertino Jr., Luis P. Iñiguez, Jez L. Marston, Douglas F. Nixon, Timothy R. Powell

Version 1 posted 21 April 2020

2,457

Downloads

Citations

Theoretical and Computational Chemistry

Working Paper

Viribus Unitis: Drug Combinations as a Treatment Against COVID-19

Eugene Muratov, Alexey Zakharov

Version 1 posted 20 April 2020

998

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Identification of promising drug candidates against Non-Structural Protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing studies

Rameez Jabeer Khan, Rajat Kumar Jha, Ekampreet Singh, Monika Jain, Gizachew Muluneh Amera, Rashmi Prabha Singh, Jayaraman Muthukumaran, Amit Kumar Singh

Version 1 posted 03 June 2020

733

Downloads

Citations

Theoretical and Computational Chemistry

Working Paper

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study

Serdar Durdagi, Busecan Aksoydan, Berna Dogan, Kader Sahin, Aida Shahraki, Necla Birgül-İyison

Version 2 posted 27 April 2020

3,403

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Drug Repurposing Commonly Against Dengue Virus Capsid and SARS-CoV-2 Nucleocapsid: An in Silico Approach

Debica Mukherjee, Rupesh Roy, UPASANA RAY

Version 2 posted 15 July 2020

879

Downloads

Biological and Medicinal Chemistry

Working Paper

Novel Inhibitors of the Main Protease of SARS-CoV-2 Identified via a Molecular Dynamics Simulation-Guided in Vitro Assay

Jennifer Loschwitz, Anna Jäckering, Monika Keutmann, Maryam Olagunju, Raphael J. Eberle, Monika A. Coronado, Olujide O. Olubiyi, Birgit Strodel

Version 1 posted 09 November 2020

930

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

A machine learning platform to estimate anti-SARS-CoV-2 activities

Govinda KC, Giovanni Bocci, Srijan Verma, Mahmudulla Hassan, Jayme Holmes, Jeremy Yang, suman sirimulla, Tudor I. Oprea

Version 3 posted 19 March 2021

1,291

Downloads

Theoretical and Computational Chemistry

Working Paper

Molecular Modelling Reveals Eight Novel Druggable Binding Sites in SARS-CoV-2’s Spike Protein

Ilke Ugur Marion, Antoine Marion

Version 2 posted 08 December 2020

1,015

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Repurposing Known Drugs as Covalent and Non-Covalent Inhibitors of the SARS-CoV-2 Papain-like Protease

Pietro Delre, Fabiana Caporuscio, Michele Saviano, Giuseppe Felice Mangiatordi

Version 1 posted 12 August 2020

529

Downloads

Search

Refine Search

58 results in drug repurposing in Keywords: drug repurposing

In Silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19

Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach

Viribus Unitis: Drug Combinations as a Treatment Against COVID-19

Identification of promising drug candidates against Non-Structural Protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing studies

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study

Drug Repurposing Commonly Against Dengue Virus Capsid and SARS-CoV-2 Nucleocapsid: An in Silico Approach

Novel Inhibitors of the Main Protease of SARS-CoV-2 Identified via a Molecular Dynamics Simulation-Guided in Vitro Assay

A machine learning platform to estimate anti-SARS-CoV-2 activities

Molecular Modelling Reveals Eight Novel Druggable Binding Sites in SARS-CoV-2’s Spike Protein

Repurposing Known Drugs as Covalent and Non-Covalent Inhibitors of the SARS-CoV-2 Papain-like Protease

58 results in Keywords: drug repurposing